Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
Authors
Thomas B. Siler
Daniel Reyner
Margot MacDonald-Berko
John D. Davidson
Kathleen Rickard
Tara Rheault
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
Thomas B. Siler, Daniel Reyner, Margot MacDonald-Berko, John D. Davidson et al.
Journal
International Journal of COPD
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
article
Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
Thomas B. Siler, Daniel Reyner, Margot MacDonald-Berko, John D. Davidson, Kathleen Rickard, Tara Rheault
article en
Abstract
No abstract available for this paper.
Publication Tag
International Journal of COPDVol. Volume 21
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), DM-STAT (United States) (US), Lindenwood University (US)
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 63%
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research